Anti-Ms CD4 Purified Azide Free Monoclonal Antibody

CD4 antibody

Boster Bio Anti-Ms CD4 Purified Azide Free Monoclonal Antibody (Catalog# M00344-3). Tested in Flow Cytometry, IP application(s). This antibody reacts with Human.

Product Info Summary

SKU: M00344-3
Size: 0.1 mg
Reactive Species: Human
Host: Mouse
Application: Flow Cytometry, IP

Customers Who Bought This Also Bought

Product Name

Anti-Ms CD4 Purified Azide Free Monoclonal Antibody

View all CD4 Antibodies

SKU/Catalog Number

M00344-3

Size

0.1 mg

Form

Liquid

Description

Boster Bio Anti-Ms CD4 Purified Azide Free Monoclonal Antibody (Catalog# M00344-3). Tested in Flow Cytometry, IP application(s). This antibody reacts with Human.

Storage & Handling

Store at 2-8°C. Do not freeze.

Cite This Product

Anti-Ms CD4 Purified Azide Free Monoclonal Antibody (Boster Biological Technology, Pleasanton CA, USA, Catalog # M00344-3)

Host

Mouse

Contents

Phosphate buffered saline (PBS), pH 7.4, azide-free

Clonality

Monoclonal

Clone Number

BB7.2

Isotype

Mouse IgG2b

Immunogen

HLA-A2 solubilised by papain. The antibody BB7.2 recognizes an extracellular epitope at the C-terminus of alpha-2 helix and a turn on one of the underlying beta strands within the human HLA-A2 histocompatibility antigen.

Reactive Species

M00344-3 is reactive to CD4 in Human

Observed Molecular Weight

42 kDa

Calculated molecular weight

51.3 kDa

Background of CD4

HLA-A2 (44 kDa) is the most frequent HLA-A allele in human ethnic populations. HLA-A, together with HLA-B and HLA-C, represent human HLA class I major histocompatibility (MHC) antigens. These intrinsic membrane glycoproteins are expressed on nucleated cells and noncovalently associate with an invariant beta2 microglobulin. They carry foreign determinants important for immune recognition by cytotoxic T cells, thus important for anti-viral and anti-tumour defence.

Antibody Validation

Boster validates all antibodies on WB, IHC, ICC, Immunofluorescence, and ELISA with known positive control and negative samples to ensure specificity and high affinity, including thorough antibody incubations.

View more details

Applications

M00344-3 is guaranteed for Flow Cytometry, IP Boster Guarantee

Assay Dilutions Recommendation

The recommendations below provide a starting point for assay optimization. The actual working concentration varies and should be decided by the user.

Flow cytometry: 1 μg/ml.

Validation Images & Assay Conditions

Loading publications

No publications found

Do you have publications using this product? Share with us and receive a reward. Contact us for more information.

Publications not available. Please try again later.

Product has been cited in publications

No results found matching your query

  • Published: --- Journal: --- Application: --- Impact Factor: --- Species: --- PMID: --- View Article

Have you used Anti-Ms CD4 Purified Azide Free Monoclonal Antibody?

Share your experimental results or join a short interview to earn up to $1,000 in product credits or other rewards.

0 Reviews For Anti-Ms CD4 Purified Azide Free Monoclonal Antibody

Have a question?

Find answers in Q&As, reviews.

Can't find your answer?

Submit your question

0 Customer Q&As for Anti-Ms CD4 Purified Azide Free Monoclonal Antibody

Order DetailsPrice
M00344-3

0.1 mg

$323

Free Secondary Antibody

FREE  $95.00
FREE  $95.00
$40.00  $80.00
$65.00  $130.00
$67.50  $135.00
$75.00  $150.00
$30.00  $60.00
$75.00  $150.00
Choose an option to show lead time.
Get A Quote
In stock
Order Product
M00344-3
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$323.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Apr 21, 2026